These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16533155)

  • 41. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors.
    Zhou N; Xu Y; Liu X; Wang Y; Peng J; Luo X; Zheng M; Chen K; Jiang H
    Int J Mol Sci; 2015 Jun; 16(6):13407-26. PubMed ID: 26110383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A probabilistic approach to high throughput drug discovery.
    Labute P; Nilar S; Williams C
    Comb Chem High Throughput Screen; 2002 Mar; 5(2):135-45. PubMed ID: 11966422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic QSAR techniques: applications in drug design and toxicology.
    Mekenyan O
    Curr Pharm Des; 2002; 8(17):1605-21. PubMed ID: 12052203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. QSAR Methods.
    Gini G
    Methods Mol Biol; 2016; 1425():1-20. PubMed ID: 27311459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemoinformatic Approach to Assess Toxicity of Ionic Liquids.
    Sosnowska A; Rybinska-Fryca A; Barycki M; Jagiello K; Puzyn T
    Methods Mol Biol; 2018; 1800():559-571. PubMed ID: 29934911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QSAR and Classification Study on Prediction of Acute Oral Toxicity of
    Fan T; Sun G; Zhao L; Cui X; Zhong R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MoDeSuS: A Machine Learning Tool for Selection of Molecular Descriptors in QSAR Studies Applied to Molecular Informatics.
    Martínez MJ; Razuc M; Ponzoni I
    Biomed Res Int; 2019; 2019():2905203. PubMed ID: 30906770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
    Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
    Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
    Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational modeling and design of renin inhibitors.
    Subramanian G
    Bioorg Med Chem Lett; 2013 Jan; 23(2):460-5. PubMed ID: 23246323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative structure-activity relationship (QSAR) study of a series of benzimidazole derivatives as inhibitors of Saccharomyces cerevisiae.
    Podunavac-Kuzmanović SO; Cvetković DD; Jevrić LR; Uzelac NJ
    Acta Chim Slov; 2013; 60(1):26-33. PubMed ID: 23841329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
    Mansouri K; Judson RS
    Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Best Practices for QSAR Model Development, Validation, and Exploitation.
    Tropsha A
    Mol Inform; 2010 Jul; 29(6-7):476-88. PubMed ID: 27463326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase.
    Xing L; Goulet R; Johnson K
    J Chem Inf Model; 2011 Jul; 51(7):1582-92. PubMed ID: 21615155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.